# Open-label Extension Study Of RN624

> **NCT00399490** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 287 (actual)

## Conditions studied

- Osteoarthritis
- OA Knee Pain
- Arthritis

## Interventions

- **DRUG:** RN624 (PF-04383119)

## Key facts

- **NCT ID:** NCT00399490
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-15
- **Primary completion:** 2008-02-11
- **Final completion:** 2008-02-11
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399490, "Open-label Extension Study Of RN624". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00399490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*